Nanosensors for detecting enzymatic activity in dairy production

Patent metadata

Field	Value
Publication number	US-10416144-B2
Application number	US-201515329395-A
Country	US
Kind code	B2
Filing date	Jul 27, 2015
Priority date	Jul 28, 2014
Publication date	Sep 17, 2019
Grant date	Sep 17, 2019

Abstract

Methods for detecting biomarkers of inflammation, infection, and/or bacterial activity in dairy production, which indicate issues with the milk itself or issues related to the health of the cow. The methods generally comprise contacting a milk sample with a nanoplatform assembly to create an assay solution, and detecting spectral changes in the assay solution that are triggered by enzymatic activity (when present) in the sample. The nanoplatform assembly comprises a first particle, a second particle, and a linkage therebetween, wherein the linkage comprises a protease consensus sequence (the sequence of amino acids cleaved by the protease), or an ester linkage (cleaved by a protease or lipase). A plurality of second particles can also be linked to the first particle. Test strips are also described, which undergo a visual color change in the presence of the target enzyme in the milk sample.

First claim

What is claimed:

1. An in vitro method for detecting a biomarker of inflammation, infection, and/or bacterial activity in a milk sample from a cow, said method comprising:
(a) contacting a de-fatted milk sample from said cow with a buffer solution and a nanoplatform assembly to create an assay solution, said nanoplatform assembly comprising:
a first particle, wherein said first particle is a core/shell nanoparticle comprising a metal or metal-alloy core and a metal shell;
a second particle; and
an oligopeptide linkage between said first and second particles, said linkage being cleavable by a protease that is indicative of mastitis or subclinical mastitis infection in said cow and selected from the group consisting of neutrophil elastase, MMP-8, MMP9, MMP12, cathepsin B, uPA, and combinations thereof, wherein said first and second particles are separated by a distance whereby:
Förster resonance energy transfer or surface plasmon resonance occurs between said first and second particles; or
said first particle quenches an excited state of said second particle;

(b) exposing said assay solution to an excitation light source; and
(c) detecting any change in an absorption or emission spectrum of said assay solution as a measure of concentration of protease activity in said milk sample, wherein said protease is the biomarker indicative of inflammation, infection, and/or bacterial activity in said cow or said milk.

2. The method of claim 1 , wherein said first and second particles are separated by a distance of less than about 10 nm.

3. The method of claim 1 , wherein said change comprises:
a blue-shift in the absorption or emission maximum of said assay solution after said contacting relative to the absorption or emission spectrum of the assay prior to said contacting; or
the appearance of a new visible color or luminescence band relative to the absorption or emission spectrum of said assay prior to said contacting.

4. The method of claim 1 , wherein said change in absorption or emission spectrum indicates the activity of one or more of said proteases selected from the group consisting of neutrophil elastase, MMP-8, MMP9, MMP12, cathepsin B, and uPA and combinations thereof.

5. The method of claim 4 , wherein said protease activity correlates with a prognosis for mastitis infection, wherein detecting activity of neutrophil elastase, MMP-8, cathepsin B, and/or uPA indicates a prognosis for subclinical mastitis infection in said cow, or wherein detecting activity of MMP-9 and/or MMP-12 indicates a prognosis for clinical mastitis infection in said cow.

6. The method of claim 1 , wherein said contacting occurs in a microwell plate, wherein said exposing and said detecting are carried out using a microwell plate reader.

7. The method of claim 1 , wherein said second particle is selected from the group consisting of nanoparticles, chromophores/luminophores, quantum dots, viologens, and combinations thereof.

8. The method of claim 1 , wherein said nanoparticle comprises a metal selected from the group consisting of elemental metals and metal salts, said metal salts being selected from the group consisting of oxides, sulfides, selenides, and tellurides.

9. The method of claim 8 , wherein said nanoparticle comprises an alloy of two or more metals.

10. The method of claim 1 , wherein said core is selected from the group consisting of Au, Ag, Cu, Co, Fe, and Pt, and wherein said shell is selected from the group consisting of Au, Ag, Cu, Co, Fe, Pt, the metal oxides thereof, and combinations thereof.

11. The method of claim 1 , wherein said core/shell nanoparticle is selected from the group consisting of Fe/Au, Fe/Fe 3 O 4 , and Au/Fe 2 O 3 .

12. The method of claim 1 , wherein said nanoparticle is a stabilized nanoparticle comprising an organic monolayer surrounding the nanoparticle.

13. The method of claim 1 , wherein said second particle is a chromophore/luminophore selected from the group consisting of organic dyes, inorganic dyes, fluorophores, phosphophores, light absorbing nanoparticles, combinations thereof, and the metalated complexes thereof.

14. The method of claim 1 , wherein said second particle is a quantum dot selected from the group consisting of CdSe/ZnS core/shell quantum dots, CdTe/CdSe core/shell quantum dots, CdSe/ZnTe core/shell quantum dots, and alloyed semiconductor quantum dots.

15. The method of claim 1 , said nanoplatform assembly comprising a single first particle and a plurality of said second particles linked thereto via respective linkages.

16. The method of claim 15 , wherein the respective linkages between each of said plurality of second particles and said first particle each comprises a different protease consensus sequence.

17. The method of claim 15 , wherein the respective linkages between each of said plurality of second particles and said first particle each comprises a protease consensus sequence for the same type of protease.

18. The method of claim 15 , said nanoplatform assembly further comprising a third particle selected from the group consisting of nanoparticles, chromophores/luminophores, quantum dots, and viologens, said third particle being linked to said first particle by a non-cleavable linkage.

19. The method of claim 18 , said nanoplatform assembly comprising a plurality of said third particles linked to said first particle via respective non-cleavable linkages.

20. The method of claim 18 , wherein said third particle permits Forster resonance energy transfer or surface plasmon resonance occurs between said third and second particles; or said third particle quenches an excited state of said second particle.

Assignees

• Univ Kansas State

Inventors

• Troyer Deryl L
• Bossmann Stefan H
• Malalasekera Aruni P
• Samarakoon Thilani N
• Wang Hongwang
• Kalubowilage Madumali

Classifications

• G01N33/04 Primary

  Dairy products · CPC title

• C12Q1/44

  involving esterase · CPC title

• C12Q1/37

  involving peptidase or proteinase · CPC title

• C12Q1/04

  Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title

• G01N2333/952

  derived from bacteria · CPC title